December 30, 2024
Proteomics International (ASX:PIQ) leads the charge in endometriosis diagnosis revolution
Proteomics International’s breakthrough PromarkerEndo blood test offers a non-invasive, accurate diagnosis for all stages of endometriosis, potentially revolutionising women’s health care.